In the News

CHOP scientists share their expertise in circadian research and SMA treatments. This and more this week’s news.

This week’s news roundup features three studies, Doris Duke Award winners, and a commitment to the CHOP Parkway Run & Walk.

The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.

Find out how CHOP researchers create a valuable impact on children’s health in the PolicyLab 2023 Impact Report and more in this week’s research news roundup.

CHOP reaches a major milestone in pediatric cancer treatments, treating its 500th patient with CAR T-cell immunotherapy. This and more in our weekly research news roundup.

See highlights from the Third Annual Lymphatic Disorder Conference and Cellicon Valley ’23, and more in this week’s research news roundup.

U.S. News & World Report ranks CHOP No. 1 in region, and we’re proud to have eight specialties ranked in the top five.

This week In the News, the Division of Neonatology is re-selected as a Neonatal Research Network Center, and researchers develop the first pediatric brain tumor atlas.

In this week’s news roundup, CHOP’s Department of Pediatrics ranked No 1. in U.S. News & World Report’s ‘Best Pediatrics Programs’ for medical schools.

Learn about a novel disorder caused by rare genetic variants, the importance of global neonatal outcomes, and more, in this week’s edition of In the News.